trending Market Intelligence /marketintelligence/en/news-insights/trending/nrbl7fzz9okihsvyuawqsg2 content esgSubNav
In This List

Spectrum Pharmaceuticals appoints board member

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Spectrum Pharmaceuticals appoints board member

Henderson, Nev.-based Spectrum Pharmaceuticals Inc. added William Ashton to its board of directors.

Ashton was previously vice president for U.S. sales at Amgen Inc. His appointment expands the company's board to nine members.

Spectrum develops drug products for blood diseases and cancer.